跳至主要内容
临床试验/NCT07663136
NCT07663136尚未招募不适用

Finding Immune Nascent Type 1 Diabetes (FIND T1D)

Indiana University1 个研究点 分布在 1 个国家目标入组 3,800 人开始时间: 2026年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
3,800
试验地点
1

研究概览

简要总结

The goal of this clinical trial is to understand how many individuals who previously participated in the Indiana Biobank will return a type 1 diabetes home screening kit based upon different methods of recruitment communication. The main question it aims to answer is:

What form of recruitment communication is most effective for completing a type 1diabetes home screening kit?

Researchers will compare two types of recruitment contact: email and mail based communication (low-touch) versus phone contact and follow-up by a research team member (high-touch).

Participants will be contacted either via email/mail or by phone and asked if they want to complete a type 1 diabetes home screening kit.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Screening
盲法
None

入排标准

年龄范围
1 Year 至 99 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participant must be in Indiana Biobank
  • Participant must be able to provide consent
  • Ages 1-99 including pregnant women

排除标准

  • Refusal to sign informed consent for home screening is exclusionary for the home screening portion of the study
  • While other medical conditions are allowable prior diabetes diagnosis is exclusionary for home autoantibody screening

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Emily K. Sims

Associate Professor of Pediatrics

Indiana University

研究点 (1)

Loading locations...

相似试验